{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:19:40Z","timestamp":1786652380501,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Autonomous University of Sinaloa","award":["PROFAPI2015\/201"],"award-info":[{"award-number":["PROFAPI2015\/201"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejphar.2019.172699","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T16:12:44Z","timestamp":1569514364000},"page":"172699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Therapeutic effect of treatment with metformin and\/or 4-hydroxychalcone in male Wistar rats with nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"863","author":[{"given":"Selene","family":"de Jes\u00fas Acosta-Cota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa Maribel","family":"Aguilar-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosal\u00edo","family":"Ramos-Pay\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Guadalupe","family":"Rend\u00f3n Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Geovanni","family":"Romero-Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Montes-Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan I.","family":"Sarmiento-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Gabriela","family":"Plazas-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela J.","family":"Vergara-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araceli","family":"S\u00e1nchez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Centuri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulises","family":"Osuna-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.172699_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1139\/cjpp-2018-0353","article-title":"Histopathological and biochemical changes in the development of nonalcoholic fatty liver disease induced by high-sucrose diet at different times","volume":"97","author":"Acosta-Cota","year":"2019","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172699_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/2249-4863.152252","article-title":"Nonalcoholic Fatty liver disease and risk of diabetes and cardiovascular disease: what is important for primary care physicians?","volume":"4","author":"Ahmed","year":"2015","journal-title":"J. Fam. Med. Prim. Care"},{"key":"10.1016\/j.ejphar.2019.172699_bib3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/dom.12854","article-title":"Understanding and overcoming metformin gastrointestinal intolerance","volume":"19","author":"Bonnet","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2019.172699_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.diabet.2010.11.002","article-title":"Metformin and digestive disorders","volume":"37","author":"Bouchoucha","year":"2011","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.ejphar.2019.172699_bib5","first-page":"1","article-title":"Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial","author":"Cicero","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.ejphar.2019.172699_bib6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/17460441.2018.1410135","article-title":"Non-alcoholic fatty liver disease (NAFLD) models in drug discovery","volume":"13","author":"Cole","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejphar.2019.172699_bib7","series-title":"Non-alcoholic Fatty Liver Disease: Prevalence and All-Cause Mortality According to Sedentary Behaviour and Cardiorespiratory Fitness. The HUNT Study. Progress in Cardiovascular Diseases","author":"Croci","year":"2019"},{"key":"10.1016\/j.ejphar.2019.172699_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s002109900152","article-title":"Effects of metformin on intestinal 5-hydroxytryptamine (5-HT) release and on 5-HT3 receptors","volume":"361","author":"Cubeddu","year":"2000","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172699_bib9","doi-asserted-by":"crossref","DOI":"10.1590\/s2175-97902018000317343","article-title":"Synthesis of leading chalcones with high antiparasitic, against Hymenolepis nana, and antioxidant activities","volume":"54","author":"D\u00edaz-Carrillo","year":"2018","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2019.172699_bib10","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2019.172699_bib11","first-page":"637","article-title":"Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best practice & research","volume":"28","author":"Dietrich","year":"2014","journal-title":"Clin. gastroenterol."},{"key":"10.1016\/j.ejphar.2019.172699_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12325-013-0084-6","article-title":"Effect of metformin on ballooning degeneration in nonalcoholic steatohepatitis (NASH): when to use metformin in nonalcoholic fatty liver disease (NAFLD)","volume":"31","author":"Doycheva","year":"2014","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejphar.2019.172699_bib13","article-title":"Hepatoprotective activity of phloretin and hydroxychalcones against Acetaminophen Induced hepatotoxicity in mice","volume":"7","author":"Ebadollahi-Natanzi","year":"2011","journal-title":"Iran. J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2019.172699_bib14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.biopha.2017.03.079","article-title":"Metformin mitigates carbon tetrachloride-induced TGF-beta1\/Smad3 signaling and liver fibrosis in mice","volume":"90","author":"Fan","year":"2017","journal-title":"Biomed. Pharmacother. = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.ejphar.2019.172699_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.taap.2015.07.009","article-title":"Attenuation of inflammatory response by a novel chalcone protects kidney and heart from hyperglycemia-induced injuries in type 1 diabetic mice","volume":"288","author":"Fang","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172699_bib16","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease","volume":"65","author":"Fazel","year":"2016","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.ejphar.2019.172699_bib17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pharmthera.2012.11.004","article-title":"Murine models for pharmacological studies of the metabolic syndrome","volume":"137","author":"Fellmann","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2019.172699_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/jdi.12888","article-title":"Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: a randomized trial","volume":"10","author":"Feng","year":"2019","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.ejphar.2019.172699_bib19","series-title":"Guide for the Care and Use of Laboratory Animals","article-title":"Guide for the care and use of laboratory animals","year":"2011"},{"key":"10.1016\/j.ejphar.2019.172699_bib20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/00365520902845268","article-title":"Metformin in patients with non-alcoholic fatty liver disease: a randomized, controlled trial","volume":"44","author":"Haukeland","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2019.172699_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2019.02.004","article-title":"Hepatoprotective activity of metformin: a new mission for an old drug?","volume":"850","author":"Iranshahy","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172699_bib22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1590\/2359-3997000000038","article-title":"Acarbose versus trans-chalcone: comparing the effect of two glycosidase inhibitors on obese mice","volume":"59","author":"Jalalvand","year":"2015","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2019.172699_bib23","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1152\/japplphysiol.00936.2012","article-title":"Effects of endurance exercise training, metformin, and their combination on adipose tissue leptin and IL-10 secretion in OLETF rats","volume":"113","author":"Jenkins","year":"2012","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ejphar.2019.172699_bib24","first-page":"359","article-title":"Trans-chalcone enhances insulin sensitivity through the miR-34a\/SIRT1 pathway","volume":"21","author":"Karimi-Sales","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.ejphar.2019.172699_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.phrs.2017.11.022","article-title":"Chalcones as putative hepatoprotective agents: preclinical evidence and molecular mechanisms","volume":"129","author":"Karimi-Sales","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2019.172699_bib26","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.pharep.2016.03.004","article-title":"Effect of trans-chalcone on atheroma plaque formation, liver fibrosis and adiponectin gene expression in cholesterol-fed NMRI mice","volume":"68","author":"Karkhaneh","year":"2016","journal-title":"Pharmacol. Rep. : PR"},{"key":"10.1016\/j.ejphar.2019.172699_bib27","series-title":"Histolog\u00eda y Biolog\u00eda Celular: Introducci\u00f3n a la anatom\u00eda patol\u00f3gica","author":"Kierszenbaum","year":"2008"},{"key":"10.1016\/j.ejphar.2019.172699_bib28","first-page":"1","article-title":"Chalcones and their pyrazine analogs: synthesis, inhibition of aldose reductase, antioxidant activity, and molecular docking study","author":"Kucerova-Chlupacova","year":"2018","journal-title":"Monatshefte f\u00fcr Chemie-Chem. Mon."},{"key":"10.1016\/j.ejphar.2019.172699_bib29","series-title":"Enfermedad del h\u00edgado graso no alcoh\u00f3lico y esteatohepatitis no alcoh\u00f3lica","author":"LaBrecque","year":"2012"},{"key":"10.1016\/j.ejphar.2019.172699_bib30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4093\/dmj.2012.36.4.293","article-title":"Intracerebroventricular injection of metformin induces anorexia in rats","volume":"36","author":"Lee","year":"2012","journal-title":"J. Diabetes Metab."},{"key":"10.1016\/j.ejphar.2019.172699_bib31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1055\/s-0042-111514","article-title":"Pharmacokinetic\/pharmacodynamic analysis of metformin using different models in diabetic rats","volume":"66","author":"Li","year":"2016","journal-title":"Drug Res."},{"key":"10.1016\/j.ejphar.2019.172699_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3892\/ijmm.2013.1560","article-title":"Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein","volume":"33","author":"Liu","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ejphar.2019.172699_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12996","article-title":"Hypothalamic AMPK and energy balance","volume":"48","author":"Lopez","year":"2018","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2019.172699_bib34","first-page":"14","article-title":"SREBP-1c, ChREBP y LXR: su influencia en el desarrollo de h\u00edgado graso no alcoh\u00f3lico","volume":"80","author":"L\u00f3pez-Oliva","year":"2014","journal-title":"An. R. Acad. Farmac."},{"key":"10.1016\/j.ejphar.2019.172699_bib35","first-page":"161","article-title":"Hepatolog\u00eda para gastroenter\u00f3logos y hepat\u00f3logos","volume":"28","author":"L\u00f3pez-Panqueva","year":"2013","journal-title":"Rev. Colomb. Gastroenterol."},{"key":"10.1016\/j.ejphar.2019.172699_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2012.01.028","article-title":"The effect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats","volume":"1444","author":"Lv","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2019.172699_bib37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MED.0000000000000095","article-title":"Effects of metformin on weight loss: potential mechanisms","volume":"21","author":"Malin","year":"2014","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.ejphar.2019.172699_bib38","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00125-015-3844-9","article-title":"Metformin and the gastrointestinal tract","volume":"59","author":"McCreight","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2019.172699_bib39","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1055\/s-0030-1250435","article-title":"PPARalpha activation by culinary herbs and spices","volume":"77","author":"Mueller","year":"2011","journal-title":"Planta Med."},{"key":"10.1016\/j.ejphar.2019.172699_bib40","doi-asserted-by":"crossref","first-page":"553","DOI":"10.18388\/abp.2010_2443","article-title":"Core structure of flavonoids precursor as an antihyperglycemic and antihyperlipidemic agent: an in vivo study in rats","volume":"57","author":"Najafian","year":"2010","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ejphar.2019.172699_bib41","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1016\/j.tetlet.2007.03.054","article-title":"A simple and highly efficient method for the synthesis of chalcones by using borontrifluoride-etherate","author":"Narender","year":"2007","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejphar.2019.172699_bib42","article-title":"Quick-Fat diet inhibits the development of diabetes in Spontaneously Diabetic Torii (SDT) rats","volume":"42","author":"Ohta","year":"2018","journal-title":"Thai J. Pharm. Sci. (TJPS)"},{"key":"10.1016\/j.ejphar.2019.172699_bib43","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.3390\/ijms15058591","article-title":"Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation","volume":"15","author":"Peverill","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2019.172699_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/603415","article-title":"4-Hydroxychalcone attenuates hyperaldosteronism, inflammation, and renal injury in cryptochrome-null mice","volume":"2014","author":"Qu","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2019.172699_bib45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.foodchem.2010.11.011","article-title":"Hydroxychalcones as potent antioxidants: structure-activity relationship analysis and mechanism considerations","volume":"126","author":"Quian","year":"2011","journal-title":"Food Chem."},{"key":"10.1016\/j.ejphar.2019.172699_bib46","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1039\/C4TX00032C","article-title":"Up-regulation of nuclear related factor 2 (NRF2) and antioxidant responsive elements by metformin protects hepatocytes against the acetaminophen toxicity","volume":"3","author":"Ramachandran","year":"2014","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.ejphar.2019.172699_bib47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2008.12.013","article-title":"Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat","volume":"604","author":"Raso","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172699_bib48","first-page":"383","article-title":"Diet-induced obesity: rodent model for the study of obesity-related disorders","volume":"58","author":"Rosini","year":"2012","journal-title":"Rev. Assoc. Med. Bras."},{"key":"10.1016\/j.ejphar.2019.172699_bib49","doi-asserted-by":"crossref","first-page":"574832","DOI":"10.1155\/2015\/574832","article-title":"Nonalcoholic steatohepatitis: a search for factual animal models","volume":"2015","author":"Sanches","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2019.172699_bib50","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/labinvest.2012.75","article-title":"Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function","volume":"92","author":"Spruss","year":"2012","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"10.1016\/j.ejphar.2019.172699_bib51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1440-6047.2002.00306.x","article-title":"Metformin improves liver antioxidant potential in rats fed a high-fructose diet","volume":"11","author":"Srividhya","year":"2002","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"10.1016\/j.ejphar.2019.172699_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091111","article-title":"Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity","volume":"9","author":"Woo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.172699_bib53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1530\/JOE-15-0409","article-title":"Metformin improves hepatic IRS2\/PI3K\/Akt signaling in insulin-resistant rats of NASH and cirrhosis","volume":"229","author":"Xu","year":"2016","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2019.172699_bib54","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10928-015-9436-y","article-title":"Prediction and validation of enzyme and transporter off-targets for metformin","volume":"42","author":"Yee","year":"2015","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.ejphar.2019.172699_bib55","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/1750-3841.13789","article-title":"Dietary intake of structured lipids with different contents of medium-chain fatty acids on obesity prevention in C57BL\/6J mice","volume":"82","author":"Zhou","year":"2017","journal-title":"J. Food Sci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991930651X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429991930651X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:31:38Z","timestamp":1757975498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429991930651X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":55,"alternative-id":["S001429991930651X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172699","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effect of treatment with metformin and\/or 4-hydroxychalcone in male Wistar rats with nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172699"}}